Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +3.68% | -4.08% | -9.62% |
05-28 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
05-28 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.62% | 194M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- SVB Leerink Adjusts Compass Therapeutics' Price Target to $11 from $9, Keeps Outperform Rating